Details
Stereochemistry | ACHIRAL |
Molecular Formula | C6H10N2O4.2Na |
Molecular Weight | 220.1341 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].[Na+].[O-]C(=O)CNCCNCC([O-])=O
InChI
InChIKey=QMIFISRIAJBCGZ-UHFFFAOYSA-L
InChI=1S/C6H12N2O4.2Na/c9-5(10)3-7-1-2-8-4-6(11)12;;/h7-8H,1-4H2,(H,9,10)(H,11,12);;/q;2*+1/p-2
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Biodegradability of ethylenediamine-based complexing agents. | 2001 Jun |
|
Improved selectivity for the binding of naphthyridine dimer to guanine-guanine mismatch. | 2001 Sep |
|
Binary and ternary complexes of cadmium(II) involving Ethylenediamine-N,N'-diacetic acid and amino acids or peptides. | 2001 Sep-Oct |
|
In vitro cell studies of technetium-99m labeled RGD-HYNIC peptide, a comparison of tricine and EDDA as co-ligands. | 2003 Feb |
|
Iron-regulated proteins (IRPS) of Leptospira biflexa serovar Patoc strain Patoc I. | 2004 Apr-Jun |
|
Evaluation of [99mTc/EDDA/HYNIC0]octreotide derivatives compared with [111In-DOTA0,Tyr3, Thr8]octreotide and [111In-DTPA0]octreotide: does tumor or pancreas uptake correlate with the rate of internalization? | 2005 Sep |
|
99mTc-labeled cyclic RGDfK dimer: initial evaluation for SPECT imaging of glioma integrin alphavbeta3 expression. | 2006 Jul-Aug |
|
Preclinical evaluation of [99mTc/EDDA/tricine/HYNIC0, 1-Nal3, Thr8]-octreotide as a new analogue in the detection of somatostatin-receptor-positive tumors. | 2007 Aug |
|
Impact of ligand protonation on eigen-type metal complexation kinetics in aqueous systems. | 2007 Mar 22 |
|
The hemolytic and cytolytic activities of Serratia marcescens phospholipase A (PhlA) depend on lysophospholipid production by PhlA. | 2009 Dec 16 |
Patents
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1651598
Created by
admin on Sat Dec 16 08:02:11 GMT 2023 , Edited by admin on Sat Dec 16 08:02:11 GMT 2023
|
PRIMARY | RxNorm | ||
|
EQL53S5L0F
Created by
admin on Sat Dec 16 08:02:11 GMT 2023 , Edited by admin on Sat Dec 16 08:02:11 GMT 2023
|
PRIMARY | |||
|
38011-25-5
Created by
admin on Sat Dec 16 08:02:11 GMT 2023 , Edited by admin on Sat Dec 16 08:02:11 GMT 2023
|
PRIMARY | |||
|
61974
Created by
admin on Sat Dec 16 08:02:11 GMT 2023 , Edited by admin on Sat Dec 16 08:02:11 GMT 2023
|
PRIMARY | |||
|
EQL53S5L0F
Created by
admin on Sat Dec 16 08:02:11 GMT 2023 , Edited by admin on Sat Dec 16 08:02:11 GMT 2023
|
PRIMARY | |||
|
DTXSID0049575
Created by
admin on Sat Dec 16 08:02:11 GMT 2023 , Edited by admin on Sat Dec 16 08:02:11 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD